186 related articles for article (PubMed ID: 23536032)
21. Miscellaneous cancers (lung, thyroid, renal cancer, myeloma, and neuroendocrine tumors): role of SPECT and PET in imaging bone metastases.
Chua S; Gnanasegaran G; Cook GJ
Semin Nucl Med; 2009 Nov; 39(6):416-30. PubMed ID: 19801221
[TBL] [Abstract][Full Text] [Related]
22. Staging of neuroendocrine tumours: comparison of [⁶⁸Ga]DOTATOC multiphase PET/CT and whole-body MRI.
Schraml C; Schwenzer NF; Sperling O; Aschoff P; Lichy MP; Müller M; Brendle C; Werner MK; Claussen CD; Pfannenberg C
Cancer Imaging; 2013 Mar; 13(1):63-72. PubMed ID: 23466785
[TBL] [Abstract][Full Text] [Related]
23. New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.
Evangelista L; Briganti A; Fanti S; Joniau S; Reske S; Schiavina R; Stief C; Thalmann GN; Picchio M
Eur Urol; 2016 Jul; 70(1):161-175. PubMed ID: 26850970
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
[TBL] [Abstract][Full Text] [Related]
25. [Comparison of high resolution whole-body MRI using parallel imaging and PET-CT. First experiences with a 32-channel MRI system].
Schmidt GP; Baur-Melnyk A; Tiling R; Hahn K; Reiser MF; Schoenberg SO
Radiologe; 2004 Sep; 44(9):889-98. PubMed ID: 15349732
[TBL] [Abstract][Full Text] [Related]
26. [Whole-body staging of malignant melanoma: advantages, limitations and current importance of PET-CT, whole-body MRI and PET-MRI].
Pfannenberg C; Schwenzer N
Radiologe; 2015 Feb; 55(2):120-6. PubMed ID: 25589421
[TBL] [Abstract][Full Text] [Related]
27. The role of ultrasound in primary workup of cervical cancer staging (ESGO, ESTRO, ESP cervical cancer guidelines).
Fischerová D; Cibula D
Ceska Gynekol; 2019; 84(1):40-48. PubMed ID: 31213057
[TBL] [Abstract][Full Text] [Related]
28. The clinical application of PET/CT: a contemporary review.
Brady Z; Taylor ML; Haynes M; Whitaker M; Mullen A; Clews L; Partridge M; Hicks RJ; Trapp JV
Australas Phys Eng Sci Med; 2008 Jun; 31(2):90-109. PubMed ID: 18697701
[TBL] [Abstract][Full Text] [Related]
29. Radiology's role in the battle against pediatric cancers.
Gunderman RB; Transue DL
Acad Radiol; 2012 Oct; 19(10):1300-3. PubMed ID: 22958723
[No Abstract] [Full Text] [Related]
30. CT and MRI in monitoring response: state-of-the-art and future developments.
D'Ippolito G; Torres LR; Saito Filho CF; Ferreira RM
Q J Nucl Med Mol Imaging; 2011 Dec; 55(6):603-19. PubMed ID: 22231581
[TBL] [Abstract][Full Text] [Related]
31. Translational molecular imaging for cancer.
Pomper MG
Cancer Imaging; 2005 Nov; 5 Spec No A(Spec No A):S16-26. PubMed ID: 16361132
[TBL] [Abstract][Full Text] [Related]
32. PET/CT for the staging and follow-up of patients with malignancies.
Poeppel TD; Krause BJ; Heusner TA; Boy C; Bockisch A; Antoch G
Eur J Radiol; 2009 Jun; 70(3):382-92. PubMed ID: 19406595
[TBL] [Abstract][Full Text] [Related]
33. Imaging requirements for personalized medicine: the oncologists point of view.
Kruse V; Belle SV; Cocquyt V
Curr Pharm Des; 2014; 20(14):2234-49. PubMed ID: 24025098
[TBL] [Abstract][Full Text] [Related]
34. Simultaneous 68Ga-DOTATOC PET/MRI in patients with gastroenteropancreatic neuroendocrine tumors: initial results.
Beiderwellen KJ; Poeppel TD; Hartung-Knemeyer V; Buchbender C; Kuehl H; Bockisch A; Lauenstein TC
Invest Radiol; 2013 May; 48(5):273-9. PubMed ID: 23493121
[TBL] [Abstract][Full Text] [Related]
35. Oncologic PET/MRI, part 1: tumors of the brain, head and neck, chest, abdomen, and pelvis.
Buchbender C; Heusner TA; Lauenstein TC; Bockisch A; Antoch G
J Nucl Med; 2012 Jun; 53(6):928-38. PubMed ID: 22582048
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the potential of PET-MRI fusion for detection of liver metastases in patients with neuroendocrine tumours.
Schreiter NF; Nogami M; Steffen I; Pape UF; Hamm B; Brenner W; Röttgen R
Eur Radiol; 2012 Feb; 22(2):458-67. PubMed ID: 21904802
[TBL] [Abstract][Full Text] [Related]
37. [Combination of radiological and nuclear medical imaging in animals: an overview about today's possibilities].
Behe M; Keil B; Alfke H; Böhm I; Kiessling A; Gotthardt M; Heverhagen JT
Rofo; 2007 Aug; 179(8):796-803. PubMed ID: 17638172
[TBL] [Abstract][Full Text] [Related]
38. Pediatric oncology and the future of oncological imaging.
Voss SD
Pediatr Radiol; 2011 May; 41 Suppl 1():S172-85. PubMed ID: 21523594
[TBL] [Abstract][Full Text] [Related]
39. 18F-FDG PET/CT and whole-body MRI diagnostic performance in M staging for non-small cell lung cancer: a systematic review and meta-analysis.
Machado Medeiros T; Altmayer S; Watte G; Zanon M; Basso Dias A; Henz Concatto N; Hoefel Paes J; Mattiello R; de Souza Santos F; Mohammed TL; Verma N; Hochhegger B
Eur Radiol; 2020 Jul; 30(7):3641-3649. PubMed ID: 32125513
[TBL] [Abstract][Full Text] [Related]
40. Diffusion-weighted imaging as part of hybrid PET/MRI protocols for whole-body cancer staging: does it benefit lesion detection?
Buchbender C; Hartung-Knemeyer V; Beiderwellen K; Heusch P; Kühl H; Lauenstein TC; Forsting M; Antoch G; Heusner TA
Eur J Radiol; 2013 May; 82(5):877-82. PubMed ID: 23428414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
